Product Code: GVR-1-68038-100-9
Proteomics Market Growth & Trends:
The global proteomics market size is expected to reach USD 58.16 billion in 2030 and is projected to grow at a CAGR of 12.9% from 2025 to 2030, according to a new report by Grand View Research, Inc. The major factors driving theindustry growth are a rise in the demand for personalized medicine, an expansion of the pipeline of diagnostics utilizing proteomics mass spectrometry as well as biochip platforms, and discoveries based on genomics. Moreover, owing to the importance of proteomics in drug development, numerous pharmaceutical companies have established their own proteomic divisions, which are fueling the expansion of the global industry. For instance, in September 2021, Biognosys, announced the collaboration with Evotec, to promote the use of next-generation proteomics in clinical research and drug discovery.
The COVID-19 outbreak is expected to have a significant impact on the industry, as researchers across the world are concentrating on decoding 3D structures of SARS-CoV-2 proteins. To create effective medications and biological products against COVID-19, scientists are also attempting to examine the identification techniques, structures, characterization, and interactions of these proteins. The protein structure of virus proteins and their specific locations must be understood to find a novel, efficient target treatment medication for a virus. Therefore, it will increase the demand for drug development for COVID-19 and propel industry growth. The growing need for customized medications increased R&D spending, and technological developments related to proteomics components are also driving the market.
In addition, attractive market expansion potential for proteomics is anticipated to come from improvements in mass spectrometry-based proteomics and lucrative opportunities related to biomarker identification. Thereby, propelling the market growth.The introduction of new and improved proteomics techniques by major industry participants is projected to further accelerate the growth of the industry. For instance, to provide quick data acquisition for shotgun proteomics, Bruker Corp. introduced the timsTOF Pro system for Parallel Accumulation And Serial Fragmentation (PASEF) mass spectrometry in September 2017. This system uses proprietary Trapped Ion Mobility Spectrometry (TIMS) technology.Furthermore, proteomic research advancements have accelerated the detection of protein biomarkers, protein biochips & pharmacoproteomics, and proteomics-based molecular diagnostics, which have all made significant contributions to the development of personalized medicine.
Proteomics Market Report Highlights:
- Chronic diseases, such as cardiovascular conditions, diabetes, and cancer, account for a substantial portion of global morbidity and mortality.
- The proteomics industry is experiencing a significant degree of innovation driven by technological advancements in mass spectrometry and next-generation sequencing technology.
- The reagents & consumables segment accounted for the largest revenue share of 72.53% in 2024. Kits designed for mass spectrometry enable researchers to identify proteins within complex biological samples accurately
- The spectrometry segment captured the largest revenue share of 31.88% in 2024. It is also expected to expand further at the highest during the forecast period
- The drug discovery segment dominated the proteomics market with the largest revenue share of 52.73% in 2024. This large share can be attributed to the development of structure-based drug design, a greater emphasis on creating personalized drugs, and increased investments in these areas.
- North America Proteomics market dominated the global market and accounted for 45.75% revenue share in 2024, owing to the advancements in technology and growing demand for advanced disease diagnostics
Table of Contents
Chapter 1. Methodology and Scope
- 1.1. Market Segmentation & Scope
- 1.2. Market Definitions
- 1.2.1. Product & Service Segment
- 1.2.2. Application Segment
- 1.2.3. Technology Segment
- 1.3. Information analysis
- 1.3.1. Market formulation & data visualization
- 1.4. Data validation & publishing
- 1.5. Information Procurement
- 1.6. Information or Data Analysis
- 1.7. Market Formulation & Validation
- 1.8. Market Model
- 1.9. Total Market: CAGR Calculation
- 1.10. Objectives
Chapter 2. Executive Summary
- 2.1. Market Outlook
- 2.2. Segment Snapshot
- 2.3. Competitive Insights Landscape
Chapter 3. Proteomics Market Variables, Trends & Scope
- 3.1. Market Lineage Outlook
- 3.1.1. Parent market outlook
- 3.1.2. Related/ancillary market outlook.
- 3.2. Market Dynamics
- 3.2.1. Market driver analysis
- 3.2.1.1. Rising prevalence of chronic and infectious diseases
- 3.2.1.2. Growing preference for personalized medicine
- 3.2.1.3. Technological advancements in proteomics techniques
- 3.2.2. Market restraint analysis
- 3.2.2.1. High cost of proteomics tools and instruments
- 3.3. Proteomics Market Analysis Tools
- 3.3.1. Industry Analysis - Porter's
- 3.3.2. PESTEL Analysis
- 3.3.3. COVID-19 Impact Analysis
Chapter 4. Proteomics Market: Product & Service Estimates & Trend Analysis
- 4.1. Segment Dashboard
- 4.2. Global Proteomics Market Product & Service Movement Analysis
- 4.3. Global Proteomics Market Size & Trend Analysis, by Product & Service, 2018 to 2030 (USD Million)
- 4.4. Instruments
- 4.4.1. Instruments market estimates and forecasts 2018 to 2030 (USD Million)
- 4.5. Reagents & Consumables
- 4.5.1. Reagents & consumables market estimates and forecasts 2018 to 2030 (USD Million)
- 4.6. Services
- 4.6.1. Services market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 5. Proteomics Market: Application Estimates & Trend Analysis
- 5.1. Segment Dashboard
- 5.2. Global Proteomics Market Application Movement Analysis
- 5.3. Global Proteomics Market Size & Trend Analysis, by Application, 2018 to 2030 (USD Million)
- 5.4. Drug Discovery
- 5.4.1. Drug discovery market estimates and forecasts 2018 to 2030 (USD Million)
- 5.5. Clinical Diagnostics
- 5.5.1. Clinical diagnostics market estimates and forecasts 2018 to 2030 (USD Million)
- 5.6. Others
- 5.6.1. Others market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 6. Proteomics Market: Technology Estimates & Trend Analysis
- 6.1. Segment Dashboard
- 6.2. Global Proteomics Market Technology Movement Analysis
- 6.3. Global Proteomics Market Size & Trend Analysis, by Technology, 2018 to 2030 (USD Million)
- 6.4. Next-generation Sequencing
- 6.4.1. Next-generation sequencing market estimates and forecasts 2018 to 2030 (USD Million)
- 6.5. Microarray Instruments
- 6.5.1. Microarray instruments market estimates and forecasts 2018 to 2030 (USD Million)
- 6.6. X-ray Crystallography
- 6.6.1. X-ray crystallography market estimates and forecasts 2018 to 2030 (USD Million)
- 6.7. Spectrometry
- 6.7.1. Spectrometry market estimates and forecasts 2018 to 2030 (USD Million)
- 6.8. Chromatography
- 6.8.1. Chromatography market estimates and forecasts 2018 to 2030 (USD Million)
- 6.9. Protein Fractionation Systems
- 6.9.1. Protein fractionation systems market estimates and forecasts 2018 to 2030 (USD Million)
- 6.10. Electrophoresis
- 6.10.1. Electrophoresis market estimates and forecasts 2018 to 2030 (USD Million)
- 6.11. Surface Plasma Resonance (SPR) Systems
- 6.11.1. Surface plasma resonance (SPR) systems market estimates and forecasts 2018 to 2030 (USD Million)
- 6.12. Other Technologies
- 6.12.1. Other technologies market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 7. Proteomics Market: Regional Estimates & Trend Analysis
- 7.1. Regional Market Share Analysis, 2024 & 2030
- 7.2. Regional Market Dashboard
- 7.3. Market Size, & Forecasts Trend Analysis, 2018 to 2030:
- 7.4. North America
- 7.4.1. North America market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.2. U.S.
- 7.4.2.1. Key country dynamics
- 7.4.2.2. Competitive scenario
- 7.4.2.3. Regulatory framework
- 7.4.2.4. U.S. market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.3. Canada
- 7.4.3.1. Key country dynamics
- 7.4.3.2. Competitive scenario
- 7.4.3.3. Regulatory framework
- 7.4.3.4. Canada market estimates and forecasts 2018 to 2030 (USD Million)
- 7.4.4. Mexico
- 7.4.4.1. Key country dynamics
- 7.4.4.2. Competitive scenario
- 7.4.4.3. Regulatory framework
- 7.4.4.4. Mexico market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5. Europe
- 7.5.1. Europe market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.2. UK
- 7.5.2.1. Key country dynamics
- 7.5.2.2. Competitive scenario
- 7.5.2.3. Regulatory framework
- 7.5.2.4. UK market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.3. Germany
- 7.5.3.1. Key country dynamics
- 7.5.3.2. Competitive scenario
- 7.5.3.3. Regulatory framework
- 7.5.3.4. Germany market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.4. France
- 7.5.4.1. Key country dynamics
- 7.5.4.2. Competitive scenario
- 7.5.4.3. Regulatory framework
- 7.5.4.4. France market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.5. Italy
- 7.5.5.1. Key country dynamics
- 7.5.5.2. Competitive scenario
- 7.5.5.3. Regulatory framework
- 7.5.5.4. Italy market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.6. Spain
- 7.5.6.1. Key country dynamics
- 7.5.6.2. Competitive scenario
- 7.5.6.3. Regulatory framework
- 7.5.6.4. Spain market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.7. Norway
- 7.5.7.1. Key country dynamics
- 7.5.7.2. Competitive scenario
- 7.5.7.3. Regulatory framework
- 7.5.7.4. Norway market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.8. Sweden
- 7.5.8.1. Key country dynamics
- 7.5.8.2. Competitive scenario
- 7.5.8.3. Regulatory framework
- 7.5.8.4. Sweden market estimates and forecasts 2018 to 2030 (USD Million)
- 7.5.9. Denmark
- 7.5.9.1. Key country dynamics
- 7.5.9.2. Competitive scenario
- 7.5.9.3. Regulatory framework
- 7.5.9.4. Denmark market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6. Asia Pacific
- 7.6.1. Asia Pacific market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.2. Japan
- 7.6.2.1. Key country dynamics
- 7.6.2.2. Competitive scenario
- 7.6.2.3. Regulatory framework
- 7.6.2.4. Japan market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.3. China
- 7.6.3.1. Key country dynamics
- 7.6.3.2. Competitive scenario
- 7.6.3.3. Regulatory framework
- 7.6.3.4. China market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.4. India
- 7.6.4.1. Key country dynamics
- 7.6.4.2. Competitive scenario
- 7.6.4.3. Regulatory framework
- 7.6.4.4. India market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.5. Australia
- 7.6.5.1. Key country dynamics
- 7.6.5.2. Competitive scenario
- 7.6.5.3. Regulatory framework
- 7.6.5.4. Australia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.6. South Korea
- 7.6.6.1. Key country dynamics
- 7.6.6.2. Competitive scenario
- 7.6.6.3. Regulatory framework
- 7.6.6.4. South Korea market estimates and forecasts 2018 to 2030 (USD Million)
- 7.6.7. Thailand
- 7.6.7.1. Key country dynamics
- 7.6.7.2. Competitive scenario
- 7.6.7.3. Regulatory framework
- 7.6.7.4. Thailand market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7. Latin America
- 7.7.1. Latin America market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.2. Brazil
- 7.7.2.1. Key country dynamics
- 7.7.2.2. Competitive scenario
- 7.7.2.3. Regulatory framework
- 7.7.2.4. Brazil market estimates and forecasts 2018 to 2030 (USD Million)
- 7.7.3. Argentina
- 7.7.3.1. Key country dynamics
- 7.7.3.2. Competitive scenario
- 7.7.3.3. Regulatory framework
- 7.7.3.4. Argentina market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8. MEA
- 7.8.1. MEA market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.2. South Africa
- 7.8.2.1. Key country dynamics
- 7.8.2.2. Competitive scenario
- 7.8.2.3. Regulatory framework
- 7.8.2.4. South Africa market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.3. Saudi Arabia
- 7.8.3.1. Key country dynamics
- 7.8.3.2. Competitive scenario
- 7.8.3.3. Regulatory framework
- 7.8.3.4. Saudi Arabia market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.4. UAE
- 7.8.4.1. Key country dynamics
- 7.8.4.2. Competitive scenario
- 7.8.4.3. Regulatory framework
- 7.8.4.4. UAE market estimates and forecasts 2018 to 2030 (USD Million)
- 7.8.5. Kuwait
- 7.8.5.1. Key country dynamics
- 7.8.5.2. Competitive scenario
- 7.8.5.3. Regulatory framework
- 7.8.5.4. Kuwait market estimates and forecasts 2018 to 2030 (USD Million)
Chapter 8. Competitive Landscape
- 8.1. Company/Competition Categorization
- 8.2. Strategy Mapping
- 8.3. Company Market Position Analysis, 2024
- 8.4. Company Profiles/Listing
- 8.4.1. Illumina Inc.
- 8.4.1.1. Company overview
- 8.4.1.2. Financial performance
- 8.4.1.3. Product/Service benchmarking
- 8.4.1.4. Strategic initiatives
- 8.4.2. Agilent Technologies Inc.
- 8.4.2.1. Company overview
- 8.4.2.2. Financial performance
- 8.4.2.3. Product/Service benchmarking
- 8.4.2.4. Strategic initiatives
- 8.4.3. Bio-Rad Laboratories, Inc.
- 8.4.3.1. Company overview
- 8.4.3.2. Financial performance
- 8.4.3.3. Product/Service benchmarking
- 8.4.3.4. Strategic initiatives
- 8.4.4. Thermo Fisher Scientific, Inc.
- 8.4.4.1. Company overview
- 8.4.4.2. Financial performance
- 8.4.4.3. Product/Service benchmarking
- 8.4.4.4. Strategic initiatives
- 8.4.5. Bruker Corporation
- 8.4.5.1. Company overview
- 8.4.5.2. Financial performance
- 8.4.5.3. Product/Service benchmarking
- 8.4.5.4. Strategic initiatives
- 8.4.6. F. Hoffmann-La Roche Ltd.
- 8.4.6.1. Company overview
- 8.4.6.2. Financial performance
- 8.4.6.3. Product/Service benchmarking
- 8.4.6.4. Strategic initiatives
- 8.4.7. Waters Corporation
- 8.4.7.1. Company overview
- 8.4.7.2. Financial performance
- 8.4.7.3. Product/Service benchmarking
- 8.4.7.4. Strategic initiatives
- 8.4.8. Merck KGaA
- 8.4.8.1. Company overview
- 8.4.8.2. Financial performance
- 8.4.8.3. Product/Service benchmarking
- 8.4.8.4. Strategic initiatives
- 8.4.9. Danaher
- 8.4.9.1. Company overview
- 8.4.9.2. Financial performance
- 8.4.9.3. Product/Service benchmarking
- 8.4.9.4. Strategic initiatives
- 8.4.10. Standard BioTools Inc.
- 8.4.10.1. Company overview
- 8.4.10.2. Financial performance
- 8.4.10.3. Product/Service benchmarking
- 8.4.10.4. Strategic initiatives